- Filed
- May 8, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 5, 2026 | 15M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 14.57M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 14.37M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $1.29M |
| Stock Repurchased | Q1 2026 · Mar 31, 2025 | $1.85M |
| Capex | Q1 2026 · Mar 31, 2026 | $1.08M |
| Capex | Q1 2026 · Mar 31, 2025 | $358K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $15.45M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | $5.76M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $160.47M |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $161.24M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $3.38M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $3.38M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $35.42M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $24.85M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $178.69M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $177.96M |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $166.88M |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $167.07M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $61.5M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $57.96M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $228.85M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $224.57M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $109.7M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $104.64M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $407.54M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $402.53M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.03 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.03 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.03 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $24.16M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $19.46M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $7.45M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $8.25M |
| Net Income | Q1 2026 · Mar 31, 2026 | $506K |
| Net Income | Q1 2026 · Mar 31, 2025 | $459K |
| Operating Income | Q1 2026 · Mar 31, 2026 | $3.06M |
| Operating Income | Q1 2026 · Mar 31, 2025 | $8.16M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $38.35M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $39.51M |
| Revenue | Q1 2026 · Mar 31, 2026 | $86.27M |
| Revenue | Q1 2026 · Mar 31, 2025 | $87.21M |